Navigation Links
Leukemia drug found to stimulate immunity against many cancer types
Date:6/11/2014

mice in which p110δ was blocked survived breast cancer for almost twice as long as mice with active p110δ. Their cancers also spread significantly less, with far fewer and smaller tumours developing. Survival after surgical removal of primary breast cancer tumours was also vastly improved, which has important clinical implications for stopping breast cancer from returning following surgery. The team's data further show that following p110δ inhibition, the immune system could develop an effective memory response to completely fight off the cancer.

Lead author Dr Khaled Ali, who is now based at Amgen, San Francisco, says: "When we first introduced tumours in p110δ-deficient mice, we expected them to grow faster because p110δ is important for the immune system. Instead, some tumours started shrinking. When we investigated this unexpected effect, we found that p110δ is especially important in so-called regulatory T cells which are suppressive immune cells that the tumours engage to protect themselves against immune attack."

The p110δ enzyme is a member of the PI3-kinase family, and is sometimes called PI3Kδ. p110δ and the other PI3Ks are hot drug targets for the pharmaceutical industry as they are implicated in many cancers and are readily druggable.

"Our work shows that p110δ inhibitors can shift the balance from the cancer becoming immune to our body's defences towards the body becoming immune to the cancer, by disabling regulatory T cells," says study co-leader Dr Klaus Okkenhaug of the Babraham Institute. "This provides a rationale for using these drugs against both solid and blood cancers, possibly alongside cancer vaccines, cell therapies and other treatments that further promote tumour-specific immune responses."

Professor Nic Jones, Cancer Research UK's chief scientist and director of the Manchester Cancer Research Centre, said: "Treatments that train the immune system to recog
'/>"/>

Contact: Harry Dayantis
h.dayantis@ucl.ac.uk
44-020-310-83844
University College London
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. One in 4 children with leukemia not taking maintenance medication, study shows
2. Mechanisms of ibrutinib resistance identified in chronic lymphocytic leukemia
3. Tiny mutation triggers drug resistance for patients with one type of leukemia
4. Major discovery on the mechanism of drug resistance in leukemia and other cancers
5. New drug for non-Hodgkin lymphoma and chronic lymphocytic leukemia passes early test
6. Novel target found for chemotherapy-resistant leukemia cells
7. Moffitt Cancer Centers phase 3 study may be game-changer for acute myeloid leukemia
8. A gene within a gene contributes to the aggressiveness of acute myeloid leukemia
9. Experimental drug shows promise for treatment-resistant leukemias
10. Chemo-free treatment a possibility for leukemia/lymphoma
11. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... September 02, 2014 Michigan’s health care ... Care Act and the Healthy Michigan Plan. Throughout these ... remains a trusted funding resource for under-served individuals. Federal ... uninsured or underinsured women between the ages of 50 ... 250 percent of the federal poverty level. ...
(Date:9/2/2014)... 02, 2014 Recently, Os-Monitor.com, an innovative ... announced its new collection of employee internet monitoring products ... providing big discounts, up to 10% off, on these ... now selling more than 20 different kinds of high ... are very useful for companies of all sizes. With ...
(Date:9/2/2014)... Tuesday 2 September 2014: A simple awareness campaign in ... according to research presented at ESC Congress today by ... "Atrial fibrillation (AF) is the most common cardiac arrhythmia. ... three-fold and the risk of stroke risk by five-fold. ... of 4 cases. However, AF is often overlooked and ...
(Date:9/2/2014)... Aliso Viejo, California (PRWEB) September 02, 2014 ... X plugins have announced a new ProIntro Lesson from ... ability to create easy and fresh-looking titles,” said Christina ... between professional and armature, ProIntro is a definite game ... sequence with the ProIntro Lesson from Pixel Film Studios. ...
(Date:9/2/2014)... September 02, 2014 “Harmonicas have ... a decade, primarily to help people with COPD ... are three developed systems,” says Dana Keller, PhD, ... differ, the goals are much the same – ... some type of harmonica.” , The three approaches ...
Breaking Medicine News(10 mins):Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 3Health News:Useful Employee Internet Monitoring Products Now For Sale At Os-Monitor.com 2Health News:Simple awareness campaign in general practice identifies new cases of AF 2Health News:Pixel Film Studios Released a New ProIntro Lesson Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios Released a New ProIntro Lesson Exclusively for Final Cut Pro X 3Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 2Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 3
... $6.5 Million Funding Cut to State,s Medicare,Beneficiaries, ... Care Association and the American Health Care Association ... Pryor (D) and,Representatives Marion Berry (D-1st), Vic Snyder ... helping lead efforts in the U.S. Senate,and U.S. ...
... of Human right commission of Pakistan July 2nd speaks ... release is,being issued by the Ahmadiyya Muslim Community USA:, ... Jamaat Islami) have,tried to spread unrest to other colleges. ... Ahmadi female students were locked,up in their rooms after ...
... in 8 Hispanics with type 2 disease , , WEDNESDAY, July ... most serious health issues facing Hispanics in the United States, ... been released. , The Agency for Healthcare Research and Quality ... a consumer guide aimed at the estimated one in eight ...
... long periods of time continue to be at increased ... new study in the July 15 issue of ... is an antibiotic-resistant bacterium that can cause a variety ... nostrils, although it can be found in other body ...
... Teams During Each Tour ... Stage, LAKE SUCCESS, N.Y., July 2 , WHO: ... assessment technology, WHAT: Micro-site with real-time performance ... cyclists during every stage of the Tour de France. ...
... legacy of caring begun 29,years ago by a small group ... significant Summer fundraisers, thanks to the enthusiastic support of,women who ... starting out., The 29th annual Twilight Gathering, hosted by ... from 5:30-8 p.m. at the home,of WCP President Carol Walters ...
Cached Medicine News:Health News:State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts 2Health News:State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts 3Health News:New Spanish Consumer Guide Compares Diabetes Meds 2Health News:Being an MRSA carrier increases risk of infection and death 2Health News:Polar to Feature Live Tour de France Race Data 2Health News:Area Women Gather in Milford on July 10 to Further the Mission of Women's Caring Program 2
(Date:9/2/2014)... LONDON , Sept. 2, 2014  Drug delivery ... becoming an essential part of the entire drug ... of dollars in new vaccine delivery technologies in ... syringes to skin delivery procedures. New ... finds that though the needle-free delivery sector currently ...
(Date:9/1/2014)... NEW YORK , Sept. 1, 2014 /PRNewswire/ ... report is available in its catalogue:  Drug ... http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html ... diseases, such as cancer requires extensive expenditure, in ... first step in designing a new drug involves ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market ... Scanner Industry, 2009-2019 is a professional and in-depth ... Crystallography Scanner industry . The report firstly reviews ... its classification, application and manufacturing technology. The report ... X-Ray Crystallography Scanner listing their product specification, capacity, ...
Breaking Medicine Technology:Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan 2Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan 3Drug Discovery Technologies - A Global Market Overview 2Drug Discovery Technologies - A Global Market Overview 3Drug Discovery Technologies - A Global Market Overview 4Drug Discovery Technologies - A Global Market Overview 5Drug Discovery Technologies - A Global Market Overview 6Drug Discovery Technologies - A Global Market Overview 7Drug Discovery Technologies - A Global Market Overview 8Drug Discovery Technologies - A Global Market Overview 9Drug Discovery Technologies - A Global Market Overview 10Drug Discovery Technologies - A Global Market Overview 11Drug Discovery Technologies - A Global Market Overview 12Drug Discovery Technologies - A Global Market Overview 13Drug Discovery Technologies - A Global Market Overview 14X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... CONMED's family of products allows you to ... generators feature proprietary Energy Synchronous Processing Technology. ... current and voltage in all operational modes. ... to sample current and voltage over 450,000 ...
... achieves a secure clot, targeted to the ... hemostasis is needed, when control of bleeding ... and cautery, is ineffective or impractical., CROSSEAL* ... of human Biologically Active Component (BAC) and ...
GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...
Medicine Products: